Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

T2 Biosystems CS (TTOO)

T2 Biosystems CS (TTOO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 113,121
  • Shares Outstanding, K 44,536
  • Annual Sales, $ 10,500 K
  • Annual Income, $ -51,150 K
  • 60-Month Beta 1.21
  • Price/Sales 11.07
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.31
  • Number of Estimates 3
  • High Estimate -0.28
  • Low Estimate -0.33
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -24.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.15 +18.14%
on 10/02/19
3.08 -17.53%
on 09/23/19
-0.02 (-0.78%)
since 09/18/19
3-Month
0.52 +388.46%
on 08/01/19
3.21 -20.87%
on 09/12/19
+0.88 (+53.01%)
since 07/18/19
52-Week
0.52 +388.46%
on 08/01/19
6.09 -58.29%
on 11/05/18
-2.46 (-49.20%)
since 10/18/18

Most Recent Stories

More News
T2 Biosystems Reports Granting of Inducement Awards

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on October 3,...

TTOO : 2.54 (-2.68%)
T2 Biosystems to Showcase Latest Innovations at IDWeek 2019

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will showcase its latest rapid diagnostics...

TTOO : 2.54 (-2.68%)
T2 Biosystems' T2Resistance(TM) Panel is Now Available as a Research Use Only (RUO) Test in the U.S.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that its T2Resistance Panel, which received Breakthrough...

TTOO : 2.54 (-2.68%)
T2 Biosystems to Present at the 2019 Cantor Global Healthcare Conference

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, chairman and chief executive...

TTOO : 2.54 (-2.68%)
T2 Biosystems Enters into Distribution Agreement to Expand its Innovative Rapid Diagnostic Technologies to Puerto Rico and the U.S. Virgin Islands

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it entered into an exclusive distribution agreement...

TTOO : 2.54 (-2.68%)
T2 Biosystems' T2Resistance(TM) Panel is First Diagnostic to Graduate from CARB-X Portfolio

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, and CARB-X, a global non-profit partnership...

TTOO : 2.54 (-2.68%)
T2 Biosystems Reports Granting of Inducement Awards

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on September...

TTOO : 2.54 (-2.68%)
T2 Biosystems Up 25.9%, Shares Break Through Resistance (TTOO)

T2 Biosystems (NASDAQ:TTOO) is one of today's best performing low-priced stocks, up 25.9% to $1.80 on 1.4x average daily volume. T2 Biosystems has traded 3.2 million shares thus far today, vs. average...

TTOO : 2.54 (-2.68%)
Thinking about buying stock in Aurora Cannabis, Bank of America, Francesca's, T2 Biosystems, or Yuma Energy?

InvestorsObserver issues critical PriceWatch Alerts for ACB, BAC, FRAN, TTOO, and YUMA.

ACB.TO : 4.81 (-5.87%)
BAC : 30.35 (+0.30%)
FRAN : 19.92 (-2.92%)
TTOO : 2.54 (-2.68%)
YUMA : 3.59 (-1.10%)
T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections

T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it has...

TTOO : 2.54 (-2.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade TTOO with:

Business Summary

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens,...

See More

Key Turning Points

2nd Resistance Point 2.75
1st Resistance Point 2.65
Last Price 2.54
1st Support Level 2.44
2nd Support Level 2.33

See More

52-Week High 6.09
Fibonacci 61.8% 3.96
Fibonacci 50% 3.31
Fibonacci 38.2% 2.65
Last Price 2.54
52-Week Low 0.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar